Systemic lupus erythematosus (SLE) is a potentially fatal multisystem inflammatory chronic
disorder, the etiology and pathogenesis of which remain unclear. The loss of immune …

Bronchopulmonary dysplasia (BPD) in neonates is the most common pulmonary disease
that causes neonatal mortality, has complex pathogenesis, and lacks effective treatment. It is …

Bronchopulmonary dysplasia (BPD) is a severe chronic lung illness that affects neonates,
particularly premature infants. It has far-reaching consequences for infant health and their …

Bronchopulmonary dysplasia (BPD) is a chronic and debilitating disease that can exert
serious and overwhelming effects on the physical and mental health of premature infants …

Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants, and its
main pathogenesis partly involves oxidative stress. A large number of studies have shown …

The present study investigated whether the protective effect and mechanism of
astragaloside IV (AS‑IV) on heart failure (HF) involves small ubiquitin‑like modifier (SUMO) …

Objective To address the effectiveness and safety of early airway combined utilization of
budesonide and surfactant for bronchopulmonary dysplasia (BPD) prevention in premature …

Background This systematic review and meta-analysis aimed to evaluate the efficacy and
safety of inhaled corticosteroids (budesonide, beclomethasone, or fluticasone propionate) in …

Pulmonary surfactant (PS) is one of the main treatment for neonates with respiratory distress
syndrome (RDS). Budesonide has recently been studied as an additional treatment in such …

Objective This study aimed to compare the safety and efficacy of intratracheal administration
of budesonide and surfactant with surfactant alone for bronchopulmonary dysplasia (BPD) …